OECD TG 403

OECD TG 403 is the standard for ‘Acute Inhalation Toxicity’, i.e. acute inhalation toxicity, which is listed under Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. It was first adopted in 1981 and updated in 2009. The test is an in vivo toxicity test designed to assess the acute toxic effects of a substance following a single exposure via the respiratory tract.

The main objective of the test is to determine the local and systemic toxic effects following inhalation, the LC50 value and the GHS/CLP classification. Inhalation is the primary route of exposure for volatile chemicals, gases, vapours, aerosols and inhalable particles.

The basic principle of the test is as follows:

  • The test substance is administered to the animals by inhalation using a suitable inhalation exposure system.
  • Common exposure systems include whole-body systems, nose-only systems and head-only systems. ‘Nose-only’ systems are often preferred as they minimise secondary exposure via the oral and dermal routes.
  • The physical state of the test substance (gas, vapour, aerosol, dust) has a direct impact on the preparation and characterisation of the test atmosphere.
  • The exposure time is usually 4 hours; however, depending on regulatory requirements, other time periods may also be used.
  • In the test atmosphere, both the nominal concentration and the actual (analytical) concentration must be measured and reported.
  • In the case of exposure to aerosols and particles, the particle size distribution (e.g. mass-median aerodynamic diameter, MMAD, and geometric standard deviation, GSD) must be determined.
  • The animals are kept under clinical observation for at least 14 days; respiratory findings, signs of toxicity, reversibility, changes in body weight and mortality are recorded.
  • At the end of the study, a post-mortem examination is carried out; macroscopic findings, particularly of the respiratory tract and the lungs, are documented; where necessary, a histopathological examination is carried out.

The key parameters reported in the study are:

  • The exposure concentrations used (mg/L, ppm or mg/m³)
  • Duration of exposure and exposure pattern (whole body, nose only, head only)
  • Actual concentration in the test atmosphere and analytical measurement method
  • Physical state of gas, vapour or aerosol, and particle size distribution (MMAD, GSD)
  • Clinical observations (breathing difficulties, nasal discharge, cyanosis, lethargy, etc.)
  • Changes in body weight
  • Mortality and survival times
  • Post-mortem findings and, where applicable, histopathological findings
  • LC50 value and confidence interval

GHS/CLP category for acute inhalation toxicity (separately for gas, vapour, dust/mist) and justification for the classification; animal species, sex, age and environmental conditions (temperature, humidity, air flow) usedData on measurement uncertainty and repeatability

Why is this being done?

OECD TG 403 is being carried out for the following scientific and regulatory purposes:

  • Assessment of acute inhalation toxicity: determination of the local and systemic toxic effects occurring following a single exposure via the respiratory tract
  • Determination of the LC50 value: Quantitative assessment of acute inhalation toxicity potential
  • GHS/CLP classification: Determination of the acute inhalation toxicity category of the substance (gas, vapour, dust/mist) and specification of labelling requirements
  • Assessment of the target organs of the respiratory tract: identification of local effects in the upper respiratory tract, the lungs and associated tissues
  • Support with the preparation of authorisation dossiers: for use in safety assessments of chemicals, pesticides, biocidal products, medicinal products and industrial chemicals
  • Contribution to risk assessment: Provision of baseline data for risk assessment in inhalation exposure scenarios
  • Selection of the route of exposure: Provision of baseline toxicity data for volatile substances for which the oral or dermal route is not suitable
  • Labelling and transport: Data on acute inhalation toxicity are used in the classification of chemicals for the purposes of labelling and transport
  • Evidence-based approach: a contribution to the holistic assessment of the substance in conjunction with other toxicological, physicochemical and exposure data

OECD Guideline 403 is the standard method for assessing acute inhalation toxicity. Depending on the regulatory context, alternative approaches such as OECD Guideline 433 (Fixed Concentration Procedure) and OECD Guideline 436 (Acute Toxic Class Method) may also be used.

The results should be interpreted in the context of the substance’s physicochemical properties, other data on acute toxicity, toxicity following repeated administration, and the exposure assessment.

As part of our nano-testing services, we carry out acute inhalation toxicity studies in accordance with OECD TG 403, applying scientific rigour and utilising our accredited laboratory facilities and quality management system.

Our range of services includes the following:

Study design and protocol development

  • Preparation of a study protocol in accordance with OECD TG 403
  • Selection of the exposure system (whole-body, nose-only, head-only) according to the physical state (gas, vapour, aerosol, dust) and the physicochemical properties of the test substance
  • Scientific justification for the concentration levels and the design of the preliminary tests, based on existing toxicity data and structural similarities
  • Selection of a suitable carrier (vehicle); assessment of solubility, volatility and stability
  • Determination of species, sex, age and environmental conditions (temperature, humidity, air flow)
  • Compliance with ethical approval and animal welfare requirements
  • Where appropriate, a draft plan for a preliminary trial (range-finding)

For information on the experimental design, the selection of the exposure system, the characterisation of the test atmosphere, the sample collection conditions, the test schedule and the reporting procedures for your acute inhalation toxicity studies in accordance with OECD TG 403, please contact Nano-Test.